Novavax
NVAX
NVAX
229 hedge funds and large institutions have $825M invested in Novavax in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 79 increasing their positions, 53 reducing their positions, and 41 closing their positions.
Holders
229
Holders Change
-4
Holders Change %
-1.72%
% of All Funds
3.05%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
40
Increased
79
Reduced
53
Closed
41
Calls
$65.9M
Puts
$92.9M
Net Calls
-$27M
Net Calls Change
+$13.1M
Top Buyers
| 1 |
S
1
Sanofi
Paris,
France
|
$55.3M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$39M |
| 3 |
3
Morgan Stanley
New York
|
$39.7M |
| 4 |
DTC
4
Deep Track Capital
Greenwich,
Connecticut
|
$16.1M |
| 5 |
SCM
5
Shah Capital Management
Raleigh,
North Carolina
|
$89.6M |
Top Sellers
| 1 |
1
Coatue Management
New York
|
$0 |
| 2 |
2
Bank of Montreal
Toronto,
Ontario, Canada
|
$115K |
| 3 |
3
Two Sigma Advisers
New York
|
$6.27M |
| 4 |
JF
4
Jump Financial
Chicago,
Illinois
|
$0 |
| 5 |
5
Jane Street
New York
|
$7.65M |
